Serum myeloperoxidase level is associated with heart-type fatty acid-binding protein but not troponin T in patients with chronic heart failure

Med Princ Pract. 2015;24(1):42-6. doi: 10.1159/000368717. Epub 2014 Nov 15.

Abstract

Objective: Our aim was to investigate the possible relationship between myeloperoxidase (MPO) and myocardial damage markers such as heart-type fatty acid-binding protein (H-FABP) and troponin T (TnT) in patients with chronic heart failure (HF).

Materials and methods: Forty-two consecutive patients (age range: 27-80 years) with chronic HF were enrolled in the study. Serum H-FABP, TnT and MPO levels were measured. Routine biochemical and clinical parameters were recorded. Echocardiographic examinations were performed on all patients. A linear regression analysis was performed to determine the correlates of serum H-FABP.

Results: The MPO, H-FABP and TnT levels were 255 ± 227, 60.6 ± 48.5 and 0.07 ± 0.15 ng/ml, respectively. In multiple linear regression analysis, age (β = -0.36, p = 0.006), creatinine level (β = 0.3, p = 0.024) and serum MPO level (β = 0.41, p = 0.009) were significant determinants of H-FABP levels. Bivariate predictors were not significantly associated with TnT levels in linear regression analyses.

Conclusions: The MPO was significantly associated with serum H-FABP levels but not with TnT.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Blood Urea Nitrogen
  • Chronic Disease
  • Echocardiography
  • Fatty Acid-Binding Proteins / blood*
  • Female
  • Heart Failure / blood*
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • Outpatients
  • Peroxidase / blood*
  • Troponin T / blood*
  • Turkey

Substances

  • Biomarkers
  • Fatty Acid-Binding Proteins
  • Troponin T
  • Peroxidase